I期子宫内膜癌淋巴脉管间隙浸润的高危因素分析及预测模型的构建
Analysis of High Risk Factors of Lymphatic Vascular Space Infiltration in Stage I Endometrial Carcinoma and Construction of Predictive Model
DOI: 10.12677/acm.2024.1441367, PDF,   
作者: 刘 菲, 杨兴升*:山东大学齐鲁医院妇产科,山东 济南
关键词: 子宫内膜癌淋巴脉管间隙浸润列线图Endometrial Cancer Lymph-Vascular Space Invasion Nomogram
摘要: 目的:探讨I期子宫内膜癌患者发生淋巴脉管间隙浸润(LVSI)的相关风险因素,同时构建I期子宫内膜癌发生LVSI的预测模型,用于术前评估LVSI的风险。方法:回顾性分析2019年1月至2022年12月就诊于山东大学齐鲁医院并行全面分期手术治疗的425例I期子宫内膜癌患者的临床资料,使用Logistic回归分析确定I期子宫内膜癌发生LVSI的独立危险因素,并以此作为预测因子使用R语言软件构建I期子宫内膜癌LVSI的风险预测模型,后使用ROC (Receiver Operating Characteristics)曲线下面积AUC (Area Under the ROC)、校准曲线和决策曲线分析DCA (Decision Curve Analysis)来评估该预测模型的预测性能、校准度和临床收益。结果:425例I期子宫内膜癌患者中,LVSI阳性者118例(27.7%)。单因素分析显示年龄、合并高血压、绝经、CA125水平、病理类型、肌层浸润深度、组织学分级与I期子宫内膜癌发生淋巴血管间隙浸润显著相关(P < 0.05)。多因素分析显示肌层浸润深度(OR = 6.216, 95% CI: 3.300~11.709, P < 0.001),病理类型(OR = 3.816, 95% CI: 1.122~12.985, P = 0.032 < 0.05),组织学分级(OR = 4.032, 95% CI: 1.924~8.450, P < 0.001),CA125水平(OR = 2.762, 95% CI: 1.503~5.073, P < 0.001)是I期子宫内膜癌发生淋巴血管间隙浸润的独立危险因素。以此构建的列线图预测模型有良好的预测效能(AUC = 0.812)、符合度(平均绝对误差为0.017)和较好的临床收益。结论:术前CA125 ≥ 35 U/ml、病理分型为非子宫内膜样癌、组织学分级为G3和肌层浸润 ≥ 1/2是EC患者发生LVSI的独立危险因素;基于此建立的I期子宫内膜癌发生LVSI的风险预测模型具有良好的预测效能,可用于术前评估I期子宫内膜癌患者发生LVSI的风险。
Abstract: Objective: To investigate the risk factors for lymphovascular space invasion (LVSI) in patients with stage I endometrial carcinoma and create a predictive model for evaluating the risk of LVSI in stage I endometrial carcinoma before operation. Methods: The clinical data of 425 patients with stage I endometrial cancer who underwent comprehensive staging surgery in Qilu Hospital of Shandong University from January 2019 to December 2022 were retrospectively analyzed. Logistic regression analysis was used to determine the independent risk factors for LVSI in stage I endometrial cancer. Using these factors as predictors, a risk prediction model of LVSI in stage I endometrial cancer was constructed using R language, and then the ROC curve, the decision curve analysis and calibration curve were used to evaluate the predictive performance and conformity of the prediction model. Results: Among 425 patients with stage I endometrial cancer, 118 (27.7%) were LVSI positive. Univariate analysis showed that age, hypertension, menopause, CA125 level, pathological type, depth of myometrial invasion and histological grade were significantly correlated with LVI in stage I endometrial cancer (P < 0.05). Multivariate analysis showed that the depth of myometrial invasion (OR = 6.216, 95% CI: 3.300~11.709, P < 0.001), pathological type (OR = 3.816, 95% CI: 1.122~12.985, P = 0.032 < 0.05), histological grade (OR = 4.032, 95% CI: 1.924~8.450, P < 0.001), CA125 level (OR = 2.762, 95% CI: 1.503~5.073, P < 0.001) were independent risk factors for LVI in stage I endometrial cancer. The nomogram prediction model constructed with those predictors had good prediction efficiency (AUC = 0.812), conformity (mean absolute error = 0.017) and clear clinical benefit. Conclusions: CA125 ≥ 35 U/ml, non-endometrioid carcinoma, histological grade G3 and myometrial invasion ≥ 1/2 are independent risk factors for LVSI in EC patients. The risk prediction model of LVSI in patients with stage I endometrial cancer has a good predictive efficiency, which can be used to evaluate the risk of LVSI in patients with early endometrial cancer before surgery.
文章引用:刘菲, 杨兴升. I期子宫内膜癌淋巴脉管间隙浸润的高危因素分析及预测模型的构建[J]. 临床医学进展, 2024, 14(4): 2874-2884. https://doi.org/10.12677/acm.2024.1441367

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Crosbie, E.J., Kitson, S.J., Mcalpine, J.N., et al. (2022) Endometrial Cancer. Lancet, 399, 1412-1428. [Google Scholar] [CrossRef
[3] Tung, H.J., Huang, H.J. and Lai, C.H. (2022) Adjuvant and Post-Surgical Treatment in Endometrial Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 78, 52-63. [Google Scholar] [CrossRef] [PubMed]
[4] Hahn, H., Lee, I., Kim, T., et al. (2013) Lymphovascular Space Invasion Is Highly Associated with Lymph Node Metastasis and Recurrence in Endometrial Cancer. Australian and New Zealand Journal of Obstetrics and Gynaecology, 53, 293-297. [Google Scholar] [CrossRef] [PubMed]
[5] Solmaz, U., Mat, E., Dereli, M., et al. (2015) Lymphovascular Space Invasion and Cervical Stromal Invasion Are Independent Risk Factors for Nodal Metastasis in Endometrioid Endometrial Cancer. Australian & New Zealand Journal of Obstetrics & Gynaecology, 55, 81-86. [Google Scholar] [CrossRef] [PubMed]
[6] Rossi, E.C., Kowalski, L.D., Scalici, J., et al. (2017) A Comparison of Sentinel Lymph Node Biopsy to Lymphadenectomy for Endometrial Cancer Staging (FIRES Trial): A Multicentre, Prospective, Cohort Study. Lancet Oncology, 18, 384-392. [Google Scholar] [CrossRef
[7] Guntupalli, S.R., Zighelboim, I., Kizer, N.T., et al. (2012) Lymphovascular Space Invasion Is an Independent Risk Factor for Nodal Disease and Poor Outcomes in Endometrioid Endometrial Cancer. Gynecologic Oncology, 124, 31-35. [Google Scholar] [CrossRef] [PubMed]
[8] Wright, J.D., Huang, Y., Burke, W.M., et al. (2016) Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer. Obstetrics and Gynecology, 127, 109-118. [Google Scholar] [CrossRef
[9] Kilgore, L.C., Partridge, E.E., Alvarez, R.D., et al. (1995) Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling. Gynecologic Oncology, 56, 29-33. [Google Scholar] [CrossRef] [PubMed]
[10] Cragun, J.M., Havrilesky, L.J., Calingaert, B., et al. (2005) Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer. Journal of Clinical Oncology, 23, 3668-3675. [Google Scholar] [CrossRef
[11] Creasman, W.T., Morrow, C.P., Bundy, B.N., et al. (1987) Surgical Pathologic Spread Patterns of Endometrial Cancer. A Gynecologic Oncology Group Study. Cancer, 60, 2035-2041. <2035::AID-CNCR2820601515>3.0.CO;2-8 [Google Scholar] [CrossRef
[12] Siegenthaler, F., Epstein, E., Büchi, C.A., et al. (2023) Prognostic Value of Lymphovascular Space Invasion According to the Molecular Subgroups in Endometrial Cancer. International Journal of Gynecologic Cancer, 33, 1702-1707. [Google Scholar] [CrossRef] [PubMed]
[13] Benedetti, P.P., Basile, S., Maneschi, F., et al. (2008) Systematic Pelvic Lymphadenectomy vs. No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial. JNCI: Journal of the National Cancer Institute, 100, 1707-1716. [Google Scholar] [CrossRef] [PubMed]
[14] Kitchener, H., Swart, A.M., Qian, Q., et al. (2009) Efficacy of Systematic Pelvic Lymphadenectomy in Endometrial Cancer (MRC ASTEC Trial): A Randomised Study. Lancet, 373, 125-136. [Google Scholar] [CrossRef
[15] Colombo, N., Creutzberg, C., Amant, F., et al. (2016) ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-Up. Annals of Oncology, 27, 16-41. [Google Scholar] [CrossRef] [PubMed]
[16] Oliver-Perez, M.R., Magrina, J., Villalain-Gonzalez, C., et al. (2021) Lymphovascular Space Invasion in Endometrial Carcinoma: Tumor Size and Location Matter. Surgical Oncology, 37, Article ID: 101541. [Google Scholar] [CrossRef] [PubMed]
[17] Meydanli, M.M., Aslan, K., Oz, M., et al. (2020) Is It Possible to Develop a Prediction Model for Lymphovascular Space Invasion in Endometrioid Endometrial Cancer? International Journal of Gynecological Pathology, 39, 213-220. [Google Scholar] [CrossRef
[18] Kim, S.I., Yoon, J.H., Lee, S.J., et al. (2021) Prediction of Lymphovascular Space Invasion in Patients with Endometrial Cancer. International Journal of Medical Sciences, 18, 2828-2834. [Google Scholar] [CrossRef] [PubMed]
[19] Zhou, X., Wang, H. and Wang, X. (2017) Preoperative CA125 and Fibrinogen in Patients with Endometrial Cancer: A Risk Model for Predicting Lymphovascular Space Invasion. Journal of Gynecologic Oncology, 28, e11. [Google Scholar] [CrossRef] [PubMed]
[20] Laufer, J., Scasso, S., Papadia, A., et al. (2013) Association between Tumor Diameter and Lymphovascular Space Invasion among Women with Early-Stage Endometrial Cancer. International Journal of Gynecology & Obstetrics, 123, 142-145. [Google Scholar] [CrossRef] [PubMed]
[21] Nougaret, S., Horta, M., Sala, E., et al. (2019) Endometrial Cancer MRI Staging: Updated Guidelines of the European Society of Urogenital Radiology. European Radiology, 29, 792-805. [Google Scholar] [CrossRef] [PubMed]
[22] Ytre-Hauge, S., Husby, J.A., Magnussen, I.J., et al. (2015) Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas. International Journal of Gynecological Cancer, 25, 459-466. [Google Scholar] [CrossRef
[23] Bourgioti, C., Chatoupis, K., Tzavara, C., et al. (2016) Predictive Ability of Maximal Tumor Diameter on MRI for High-Risk Endometrial Cancer. Abdominal Radiology, 41, 2484-2495. [Google Scholar] [CrossRef] [PubMed]
[24] Chen, J., Wang, X., Lv, H., et al. (2023) Development and External Validation of a Clinical-Radiomics Nomogram for Preoperative Prediction of LVSI Status in Patients with Endometrial Carcinoma. Journal of Cancer Research and Clinical Oncology, 149, 13943-13953. [Google Scholar] [CrossRef] [PubMed]
[25] Raffone, A., Travaglino, A., Raimondo, D., et al. (2022) Lymphovascular Space Invasion in Endometrial Carcinoma: A Prognostic Factor Independent from Molecular Signature. Gynecologic Oncology, 165, 192-197. [Google Scholar] [CrossRef] [PubMed]
[26] Peters, E.E.M., Léon-Castillo, A., Hogdall, E., et al. (2022) Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer. International Journal of Gynecological Pathology, 41, 227-234. [Google Scholar] [CrossRef
[27] Tortorella, L., Restaino, S., Zannoni, G.F., et al. (2021) Substantial Lymph-Vascular Space Invasion (LVSI) as Predictor of Distant Relapse and Poor Prognosis in Low-Risk Early-Stage Endometrial Cancer. Journal of Gynecologic Oncology, 32, e11. [Google Scholar] [CrossRef] [PubMed]
[28] Stålberg, K., Bjurberg, M., Borgfeldt, C., et al. (2019) Lymphovascular Space Invasion as a Predictive Factor for Lymph Node Metastases and Survival in Endometrioid Endometrial Cancer—A Swedish Gynecologic Cancer Group (SweGCG) Study. Acta Oncologica, 58, 1628-1633. [Google Scholar] [CrossRef
[29] Restaino, S., Tortorella, L., Dinoi, G., et al. (2021) Semiquantitative Evaluation of Lymph-Vascular Space Invasion in Patients Affected by Endometrial Cancer: Prognostic and Clinical Implications. European Journal of Cancer, 142, 29-37. [Google Scholar] [CrossRef] [PubMed]
[30] Jorge, S., Hou, J.Y., Tergas, A.I., et al. (2016) Magnitude of Risk for Nodal Metastasis Associated with Lymphvascular Space Invasion for Endometrial Cancer. Gynecologic Oncology, 140, 387-393. [Google Scholar] [CrossRef] [PubMed]
[31] Sari, M.E., Yalcin, I., Sahin, H., et al. (2017) Risk Factors for Paraaortic Lymph Node Metastasis in Endometrial Cancer. International Journal of Clinical Oncology, 22, 937-944. [Google Scholar] [CrossRef] [PubMed]
[32] O’Brien, D.J., Flannelly, G., Mooney, E.E. and Foley, M. (2009) Lymphovascular Space Involvement in Early Stage Well-Differentiated Endometrial Cancer Is Associated with Increased Mortality. BJOG: An International Journal of Obstetrics & Gynaecology, 116, 991-994. [Google Scholar] [CrossRef] [PubMed]
[33] Pollom, E.L., Conklin, C.M., Von Eyben, R., et al. (2016) Nomogram to Predict Risk of Lymph Node Metastases in Patients with Endometrioid Endometrial Cancer. International Journal of Gynecological Pathology, 35, 395-401. [Google Scholar] [CrossRef
[34] Folkins, A.K., Nevadunsky, N.S., Saleemuddin, A., et al. (2010) Evaluation of Vascular Space Involvement in Endometrial Adenocarcinomas: Laparoscopic vs Abdominal Hysterectomies. Modern Pathology, 23, 1073-1079. [Google Scholar] [CrossRef] [PubMed]
[35] Kumar, S., Bandyopadhyay, S., Semaan, A., et al. (2011) The Role of Frozen Section in Surgical Staging of Low Risk Endometrial Cancer. PLOS ONE, 6, e21912. [Google Scholar] [CrossRef] [PubMed]
[36] Karabagli, P., Ugras, S., Yilmaz, B.S. and Celik, C. (2015) The Evaluation of Reliability and Contribution of Frozen Section Pathology to Staging Endometrioid Adenocarcinomas. Archives of Gynecology and Obstetrics, 292, 391-397. [Google Scholar] [CrossRef] [PubMed]
[37] Chen, J., Li, L., Chen, T., et al. (2022) Predicting the Risk of Active Pulmonary Tuberculosis in People Living with HIV: Development and Validation of a Nomogram. BMC Infectious Diseases, 22, Article No. 388. [Google Scholar] [CrossRef] [PubMed]